Third Harmonic Bio, Inc.
NASDAQ Global MarketTotal Valuation
Third Harmonic Bio, Inc. carries a market capitalization of 242.79M, placing it among publicly traded companies globally. Its enterprise value stands at -121.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 242.79M |
| Enterprise Value | -121.96M |
Share Statistics
Third Harmonic Bio, Inc. currently has 44.96M shares outstanding.
| Shares Outstanding | 44.96M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.84 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | -3.52 |
| P/OCF Ratio | -3.52 |
Financial Position
Third Harmonic Bio, Inc. maintains a current ratio of 54.10, meaning it holds 54.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 54.10 |
| Quick Ratio | 53.24 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | -0.05 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -19.42 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Third Harmonic Bio, Inc.'s stock has declined approximately -60.14815% over the past 52 weeks. The 50-day moving average sits at 5.38, while the 200-day moving average is 7.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60.14815% |
| 50-Day Moving Average | 5.38 |
| 200-Day Moving Average | 7.01 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -66.25M, while operating income came in at -66.30M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -66.30M |
| Pretax Income | -53.45M |
| Net Income | -53.45M |
| EBITDA | -66.25M |
| EBIT | -66.30M |
| Earnings Per Share (EPS) | -1.26 |
Balance Sheet
Third Harmonic Bio, Inc. holds 271.61M in cash and equivalents against 3.00M in total debt, resulting in a net debt position of -271.61M. Total book value stands at -175.52M, with working capital of 270.90M providing operational flexibility.
| Cash & Cash Equivalents | 271.61M |
| Total Debt | 3.00M |
| Net Debt | -271.61M |
| Equity (Book Value) | -175.52M |
| Book Value Per Share | -4.15 |
| Working Capital | 270.90M |
Cash Flow
Third Harmonic Bio, Inc. produced -41.69M in operating cash flow over the past twelve months. After subtracting -10,000.00 in capital expenditures, free cash flow totaled -41.70M - equivalent to -0.99 per share.
| Operating Cash Flow | -41.69M |
| Capital Expenditures | -10,000.00 |
| Free Cash Flow | -41.70M |
| FCF Per Share | -0.99 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -34.43 |
| FCF Yield | -28.42 |
Scores
Third Harmonic Bio, Inc. posts an Altman Z-Score of 11.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.70 |